InnoCare Pharma Ltd Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - InnoCare Pharma Ltd - Alpha Spread

InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 11.33 CNY -2.16% Market Closed
Market Cap: 9.6B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
InnoCare Pharma Ltd

Wall Street analysts forecast InnoCare Pharma Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 14.64 CNY with a low forecast of 14.14 CNY and a high forecast of 15.44 CNY.

Lowest
Price Target
14.14 CNY
25% Upside
Average
Price Target
14.64 CNY
29% Upside
Highest
Price Target
15.44 CNY
36% Upside
InnoCare Pharma Ltd Competitors:
Price Targets
CUV
Clinuvel Pharmaceuticals Ltd
94% Upside
MAB
Mabion SA
4% Downside
REGN
Regeneron Pharmaceuticals Inc
4% Upside
GNFT
Genfit SA
117% Upside
2256
Abbisko Cayman Ltd
272% Upside
STRO
Sutro Biopharma Inc
225% Upside
ORY
Oryzon Genomics SA
250% Upside
BIOCON
Biocon Ltd
7% Downside

Revenue
Forecast

Revenue Estimate
InnoCare Pharma Ltd

For the last 1 year the compound annual growth rate for InnoCare Pharma Ltd's revenue is -40%. The projected CAGR for the next 4 years is 28%.

-40%
Past Growth
28%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
InnoCare Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
InnoCare Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is InnoCare Pharma Ltd's stock price target?
Price Target
14.64 CNY

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 14.64 CNY with a low forecast of 14.14 CNY and a high forecast of 15.44 CNY.

What is InnoCare Pharma Ltd's Revenue forecast?
Projected CAGR
28%

For the last 1 year the compound annual growth rate for InnoCare Pharma Ltd's revenue is -40%. The projected CAGR for the next 4 years is 28%.

Back to Top